Anti-Human TL1A/TNFSF15 Reference Antibody|抗人TL1A/TNFSF15参考抗体(靶标：人TL1A（TNFSF15）)
- 货号：RB9THF526016
- 价格：面议
- 点击：411
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Human |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG1-kappa |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 4mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | TNFSF15, Vascular endothelial cell growth inhibitor, VEGI, TL1, TNF ligand-related molecule 1, Tumor necrosis factor ligand superfamily member 15 |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | O95150 |
| 背景信息 | Duvakitug is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD). • Vascular endothelial growth inhibitor in human cancer (Review)., PMID:19513527 • VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth., PMID:16061878 |
| 别名 | 2648504-55-4 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 炔诺酮单抗 | 5747 |
| 磺胺氯吡嗪单抗 | 5725 |
| 呋喃苯烯酸钠单抗 | 5579 |
| 呋喃它酮代谢物（2-NPAMOZ）单抗 | 5563 |
| 呋喃西林代谢物（2-NPSEM）单抗 | 5404 |
| 磺胺喹恶啉单抗 | 5625 |
| 苯丙酸诺龙单抗 | 5541 |
| 司帕沙星单抗 | 5405 |
| 妥布霉素单抗 | 5590 |
| 甲氧氯普胺单抗 | 5476 |
| 莫能菌素单抗 | 5580 |
| 多粘菌素B（粘菌素）单抗 | 5888 |
| 磺胺类单抗 | 5770 |
| 托灭酸（托芬那酸）单抗 | 5491 |
| 卡洛芬单抗 | 5402 |
| 喹乙醇代谢物MQCA单抗 | 5585 |
| 氟尼辛单抗 | 5527 |
| 磺胺二甲嘧啶（SM2）单抗 | 5322 |
| 诺龙（19-去甲睾酮）单抗 | 5415 |
| 阿苯达唑-2-氨基砜单抗 | 5399 |